| | 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL CAS:1219805-89-6 Formula: C9 D14 H6 O2 CDN-D-7223-0.1G 174.3402 [2H]C([2H])(CO)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CO 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL CAS:1219805-89-6 Formula: C9 D14 H6 O2 CDN-D-7223-0.25G 174.3402 [2H]C([2H])(CO)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CO 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL CDN-D-7223-0.25G CDN-D-7223-0.25G 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL TRC-N649371-2.5mg #N/A 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL TRC-N649371-5mg #N/A 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL TRC-N649371-2.5mg 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL TRC-N649371-5mg 1,9-NONANE-2,2,3,3,4,4,5,5,6,6,7,7,8,8-D14-DIOL CDN-D-7223-0.1G CDN-D-7223-0.1G 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-ACETOXY-2-(N-(2-(FORMYLOXY)ETHYL)FORMAMIDO)-3-HYDROXY-10,13-DIMETHYLHEXADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-16-YL)-1-ALLYLPYRROLIDIN-1-IUM BROMIDE Formula: C32H51BrN2O6 TRC-A165660-100mg 639.66 O[C@@H]1[C@@H](N(C([H])=O)CCOC([H])=O)C[C@@]2(C)[C@](CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])C[C@H]([N+]5(CC=C)CCCC5)[C@@H]4OC(C)=O)([H])C1.[Br-] 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-ACETOXY-2-(N-(2-(FORMYLOXY)ETHYL)FORMAMIDO)-3-HYDROXY-10,13-DIMETHYLHEXADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-16-YL)-1-ALLYLPYRROLIDIN-1-IUM BROMIDE Formula: C32H51BrN2O6 TRC-A165660-100mg A165660 O[C@@H]1[C@@H](N(C([H])=O)CCOC([H])=O)C[C@@]2(C)[C@](CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])C[C@H]([N+]5(CC=C)CCCC5)[C@@H]4OC(C)=O)([H])C1.[Br-] |